Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
850140-72-6
Purity
95%
Afatinib is an antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy. It is a 4-anilinoquinazoline tyrosine kinase inhibitor.
Properties
Name
Afatinib
Smiles
CN(C)C/C=C/C(=O)NC=1C=C2C(NC=3C=CC(F)=C(Cl)C3)=NC=NC2=CC1O[C@H]4CCOC4
Targets
Please log in to see this information
SDS
BIBW2992 | Gilotrif | Tovok | afatanib | afatinib | gilotrif | giotrif
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$38
2 mg
$40
5 mg
$42
10 mg
$44
15 mg
$46
20 mg
$49
25 mg
$54
30 mg
$57
35 mg
$60
40 mg
$62
45 mg
$65
50 mg
$67
75 mg
$70
100 mg
$POA
Quantity
1
Total amount
$ 42
BIBW2992 | Gilotrif | Tovok | afatanib | afatinib | gilotrif | giotrif
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.